These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31236580)
1. Disease activity and patient reported outcome measures in Sjögren's - what are the best tools to evaluate? Seror R; Rauz S; Gosset M; Bowman SJ Rheumatology (Oxford); 2021 Aug; 60(8):3528-3539. PubMed ID: 31236580 [TBL] [Abstract][Full Text] [Related]
3. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) and Other Patient-Reported Outcomes in the Assessment of Glandular Dysfunction in Primary Sjögren's Syndrome. Ture HY; Kim NR; Nam EJ Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895373 [TBL] [Abstract][Full Text] [Related]
4. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients. Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737 [TBL] [Abstract][Full Text] [Related]
5. Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial. Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Yves Hatron P; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Saliou P; Pers JO; Seror R; Saraux A Arthritis Care Res (Hoboken); 2017 Apr; 69(4):528-535. PubMed ID: 27390310 [TBL] [Abstract][Full Text] [Related]
8. Go Ask Your Patients! PSS-QoL Reported Perception of Dryness Correlates With Lacrimal and Salivary Flow in Primary Sjögren's Syndrome. Lackner A; Bosch P; Zenz S; Horwath-Winter J; Rabensteiner DF; Hermann J; Graninger W; Stradner MH Front Med (Lausanne); 2021; 8():660580. PubMed ID: 33937295 [No Abstract] [Full Text] [Related]
9. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's. Cooper C; Wratten S; Williams-Hall R; Bookman AAM; Ndife B; Hueber W; Goswami P Rheumatol Ther; 2022 Dec; 9(6):1499-1515. PubMed ID: 36114443 [TBL] [Abstract][Full Text] [Related]
11. Baseline disease activity influences subsequent achievement of patient acceptable symptom state in Sjögren's syndrome. Park EH; Ha YJ; Kang EH; Song YW; Scofield RH; Lee YJ Rheumatology (Oxford); 2021 Jun; 60(6):2714-2724. PubMed ID: 33188390 [TBL] [Abstract][Full Text] [Related]
12. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients. Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247 [TBL] [Abstract][Full Text] [Related]
13. Fatigue in Saudi Patients with Primary Sjögren's Syndrome and Its Correlation with Disease Characteristics and Outcome Measures: A Cross-Sectional Study. AlEnzi F; Alqahtani B; Alhamad EH; Daghestani M; Tashkandy Y; Othman N; Alshahrani K; Paramasivam MP; Halwani R; Omair MA Open Access Rheumatol; 2020; 12():303-308. PubMed ID: 33293878 [TBL] [Abstract][Full Text] [Related]
14. Do the European League Against Rheumatism (EULAR) Sjögren's syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sjögren's syndrome? Omma A; Tecer D; Kucuksahin O; Sandikci SC; Yildiz F; Erten S Arch Med Sci; 2018 Jun; 14(4):830-837. PubMed ID: 30002701 [TBL] [Abstract][Full Text] [Related]
15. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Seror R; Ravaud P; Mariette X; Bootsma H; Theander E; Hansen A; Ramos-Casals M; Dörner T; Bombardieri S; Hachulla E; Brun JG; Kruize AA; Praprotnik S; Tomsic M; Gottenberg JE; Devauchelle V; Devita S; Vollenweider C; Mandl T; Tzioufas A; Carsons S; Saraux A; Sutcliffe N; Vitali C; Bowman SJ; Ann Rheum Dis; 2011 Jun; 70(6):968-72. PubMed ID: 21345815 [TBL] [Abstract][Full Text] [Related]
16. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab. Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489 [TBL] [Abstract][Full Text] [Related]
17. Assessing health-related quality of life in primary Sjögren's syndrome-The PSS-QoL. Lackner A; Stradner MH; Hermann J; Unger J; Stamm T; Graninger WB; Dejaco C Semin Arthritis Rheum; 2018 Aug; 48(1):105-110. PubMed ID: 29395257 [TBL] [Abstract][Full Text] [Related]
18. The efficacy and mechanism for action of iguratimod in primary Sjögren's syndrome patients. Jiang W; Zhang L; Zhao Y; He X; Hu C; Liu Y Int Ophthalmol; 2020 Nov; 40(11):3059-3065. PubMed ID: 32607949 [TBL] [Abstract][Full Text] [Related]
19. Validation and adaptation to Spanish of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI). Posso-Osorio I; Nieto-Aristizábal I; Soto D; Ariza C; Urbano M; Cañas CA; Echeverri A; Castillo A; Tobón GJ Reumatol Clin (Engl Ed); 2021; 17(7):388-391. PubMed ID: 34301381 [TBL] [Abstract][Full Text] [Related]
20. Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome. Jülich M; Kanne AM; Sehnert B; Budweiser S; Voll RE; Kollert F Clin Rheumatol; 2018 Sep; 37(9):2361-2366. PubMed ID: 29858711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]